t:slim X2 Insulin Pump™ with Control-IQ™ Technology Real-World Outcome - AMSL Diabetes


t:slim X2 Insulin Pump™ with Control-IQ™ Technology Real-World Outcome

Control IQ use increased TIR from 63.6% to 73.6%, which is equivalent to 2.4 hours per day, seen across all age groups. These results were evident after the first two weeks and was sustained throughout the entire year. A notable improvement was also seen overnight, with a median time in range exceeding 90% between 04:00 and 07:00, demonstrating the effectiveness of the Sleep Activity feature in Control-IQ technology. TBR remained consistent at ∼1%.

Stay informed with AMSL Diabetes

Now you can get all the latest news and updates of our products, events and resources right into your inbox.

Something went wrong. Please try again later!

Back to top